Long Term Safety and Efficacy Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis

• Status: Completed
• Trial end date: 2018-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The objective of this study is to evaluate the safety and efficacy of up to 26 weeks of treatment with calcitriol 3 mcg/g ointment when used twice daily, without occlusion, to treat pediatric subjects (2 to 16 years and 11 months of age) with mild to moderate plaque psoriasis.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Galderma; Galderma R&D
• Treatments: Calcitriol

Criteria

Inclusion Criteria:

• Male or female 2 to 16 years and 11 months of age

• Clinical diagnosis of stable mild to moderate plaque psoriasis

Exclusion Criteria:

• Other forms of psoriasis

• Hypercalcemia

• Past history of kidney stones

• Vitamin D deficiency

• Other concomitant dermatological disease